A team at Griffith University’s Institute for Glycomics in Australia has received $300,000 in funding from The Bourne Foundation, as well as a further funding pledge from Tour de Cure, to advance research into the development of blood tests for the early diagnosis of ovarian cancer. “Despite decades of research, there is currently no easily accessible, non-invasive and reliable early detection test to diagnose ovarian cancer, which leads to poor survivability rates,” Michael Jennings, PhD, a Griffith University…
You must be logged in to read/download the full post.
The post Groups Pledge Funding for Project to Develop Ovarian Cancer Blood Test appeared first on BioNewsFeeds.